Research Center for Public Health, School of Medicine, Tsinghua University, Beijing, China.
Fukangda Health International Science & Technology, Beijing, China.
Infect Dis Poverty. 2017 Nov 21;6(1):152. doi: 10.1186/s40249-017-0364-5.
By September 2016, approximately 653,865 people in China were living with HIV/AIDS (PLWHA) and 492,725 people were receiving antiretroviral therapy (ART). PLWHA frequently experience discrimination in all domains of their personal and social lives. The World Health Organization includes discrimination in its list of social determinants of health factors that have been linked to poor physical and psychological health. This paper identifies the family support enjoyed and discrimination faced by people infected with HIV and examines the effect they have on patients' quality of life (QOL) as they undergo ART in China.
We conducted this observational cohort study of ART-treated patients with HIV in Guangxi Province using a questionnaire survey at baseline, 6, 12, and 24 months, starting in 2010. Descriptive analysis was used to describe the demographic characteristics (e.g., age, sex, educational level, marital status, and employment status) of participants. Generalized estimating equations (GEE) were employed to examine the relationships between family support, discrimination, and QOL.
In the study, 90.4% (n = 281) of patients received family support at baseline, here defined as the initiation of ART, 91.8% (n = 244) received family support 6 months into ART, 95.5% (n = 220) at 12 months, and 94.3% (n = 230) at 24 months. The proportion of patients who did not feel discriminated against by their families was 87.2% (n = 274) at baseline, 90.4% (n = 229) 6 months into ART, 90.0% (n = 210) at 12 months, and 94.5% (n = 219) at 24 months. Patients' overall QOL scores were positively associated with having received family support (OR = 2.74, P = 0.040, 95% CI: 1.68-4.47), not feeling discriminated against by their families (OR = 1.3, P = 0.041, 95% CI: 1.07-1.59) or discrimination from patients themselves, including never experiencing fear of abandonment by family (OR = 2.05, P = 0.025, 95% CI: 1.49-2.82).
Family support along with no or minimal discrimination was found to contribute to QOL among people infected with HIV. Their overall QOL tended to improve significantly as ART continued. This suggests that strategies meant to improve and strengthen family support, care for PLWHA, and promote HIV screening among high-risk populations should be explored by both policy makers and researchers.
截至 2016 年 9 月,中国约有 653865 人感染艾滋病毒/艾滋病(PLWHA),492725 人接受抗逆转录病毒治疗(ART)。PLWHA 在个人和社会生活的各个领域经常遭受歧视。世界卫生组织将歧视列入其健康的社会决定因素清单,这些因素与身体和心理健康状况不佳有关。本文旨在确定感染艾滋病毒的人所享受的家庭支持和面临的歧视,并探讨其在中国接受抗逆转录病毒治疗时对患者生活质量(QOL)的影响。
我们于 2010 年开始对广西接受抗逆转录病毒治疗的 HIV 患者进行了这项观察性队列研究,使用基线、6、12 和 24 个月的问卷调查。描述性分析用于描述参与者的人口统计学特征(如年龄、性别、教育水平、婚姻状况和就业状况)。广义估计方程(GEE)用于检验家庭支持、歧视与 QOL 之间的关系。
研究中,90.4%(n=281)的患者在基线时开始接受家庭支持,即开始接受抗逆转录病毒治疗,91.8%(n=244)在接受抗逆转录病毒治疗 6 个月时接受家庭支持,95.5%(n=220)在接受抗逆转录病毒治疗 12 个月时接受家庭支持,94.3%(n=230)在接受抗逆转录病毒治疗 24 个月时接受家庭支持。90.4%(n=229)在接受抗逆转录病毒治疗 6 个月时、90.0%(n=210)在接受抗逆转录病毒治疗 12 个月时、94.5%(n=219)在接受抗逆转录病毒治疗 24 个月时,没有感到家庭歧视的患者比例分别为 87.2%(n=274)、90.0%(n=210)和 94.5%(n=219)。患者的总体 QOL 评分与接受家庭支持呈正相关(OR=2.74,P=0.040,95%CI:1.68-4.47),与未受到家庭歧视(OR=1.3,P=0.041,95%CI:1.07-1.59)或来自患者自身的歧视呈负相关,包括从未经历过家庭遗弃的恐惧(OR=2.05,P=0.025,95%CI:1.49-2.82)。
我们发现家庭支持以及几乎没有歧视有助于感染艾滋病毒的人的生活质量。随着抗逆转录病毒治疗的持续进行,他们的总体 QOL 明显改善。这表明,政策制定者和研究人员应探讨旨在改善和加强家庭支持、关爱 PLWHA 以及促进高危人群进行 HIV 筛查的策略。